At Patent Docs, Donald Zuhn says that biotech/pharma IPOs and venture funding are bouncing back. In particular, he points to Cumberland Pharmaceuticals and Seattle Genetics, which are now or soon will be (respectively) trading their common stock, and to

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

University of California, San Diego, researchers have developed a gene drive to control a fruit-destroying fly.

A new study of a β-thalassemia gene therapy appears promising, according to NPR.

Futurism writes that gene doping could be the next generation of cheating in sports.

In Nature this week: hair color genes, hybridization between 13-year and 17-year cicadas, and more.